These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 14722237)

  • 1. Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain nicotinic receptors, and brain penetration.
    Kem WR; Mahnir VM; Prokai L; Papke RL; Cao X; LeFrancois S; Wildeboer K; Prokai-Tatrai K; Porter-Papke J; Soti F
    Mol Pharmacol; 2004 Jan; 65(1):56-67. PubMed ID: 14722237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzylidene analogs of anabaseine display partial agonist and antagonist properties at the mouse 5-hydroxytryptamine(3A) receptor.
    Machu TK; Hamilton ME; Frye TF; Shanklin CL; Harris MC; Sun H; Tenner TE; Soti FS; Kem WR
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1112-9. PubMed ID: 11714901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects at a distance in alpha 7 nAChR selective agonists: benzylidene substitutions that regulate potency and efficacy.
    Papke RL; Meyer EM; Lavieri S; Bollampally SR; Papke TA; Horenstein NA; Itoh Y; Porter Papke JK
    Neuropharmacology; 2004 Jun; 46(7):1023-38. PubMed ID: 15081799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors.
    Meyer EM; Kuryatov A; Gerzanich V; Lindstrom J; Papke RL
    J Pharmacol Exp Ther; 1998 Dec; 287(3):918-25. PubMed ID: 9864273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-[(2,4-Dimethoxy)benzylidene]-anabaseine dihydrochloride protects against 6-hydroxydopamine-induced parkinsonian neurodegeneration through α7 nicotinic acetylcholine receptor stimulation in rats.
    Suzuki S; Kawamata J; Matsushita T; Matsumura A; Hisahara S; Takata K; Kitamura Y; Kem W; Shimohama S
    J Neurosci Res; 2013 Mar; 91(3):462-71. PubMed ID: 23239187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structural basis for GTS-21 selectivity between human and rat nicotinic alpha7 receptors.
    Stokes C; Papke JK; Horenstein NA; Kem WR; McCormack TJ; Papke RL
    Mol Pharmacol; 2004 Jul; 66(1):14-24. PubMed ID: 15213292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).
    Kem WR
    Behav Brain Res; 2000 Aug; 113(1-2):169-81. PubMed ID: 10942043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A computational study of the binding of 3-(arylidene) anabaseines to two major brain nicotinic acetylcholine receptors and to the acetylcholine binding protein.
    Slavov SH; Radzvilovits M; LeFrancois S; Stoyanova-Slavova IB; Soti F; Kem WR; Katritzky AR
    Eur J Med Chem; 2010 Jun; 45(6):2433-46. PubMed ID: 20236734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretical studies of Alzheimer's disease drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine (GTS-21) and its derivatives.
    Wei DQ; Sirois S; Du QS; Arias HR; Chou KC
    Biochem Biophys Res Commun; 2005 Dec; 338(2):1059-64. PubMed ID: 16256952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors.
    Kem WR; Mahnir VM; Papke RL; Lingle CJ
    J Pharmacol Exp Ther; 1997 Dec; 283(3):979-92. PubMed ID: 9399967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of benzylidene-anabaseine analogues with agonist and allosteric sites on muscle nicotinic acetylcholine receptors.
    Arias HR; Xing H; Macdougall K; Blanton MP; Soti F; Kem WR
    Br J Pharmacol; 2009 May; 157(2):320-30. PubMed ID: 19338581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous administration of a selective alpha7 nicotinic partial agonist, DMXBA, improves sensory inhibition without causing tachyphylaxis or receptor upregulation in DBA/2 mice.
    Stevens KE; Cornejo B; Adams CE; Zheng L; Yonchek J; Hoffman KL; Christians U; Kem WR
    Brain Res; 2010 Sep; 1352():140-6. PubMed ID: 20599427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
    Roncarati R; Scali C; Comery TA; Grauer SM; Aschmi S; Bothmann H; Jow B; Kowal D; Gianfriddo M; Kelley C; Zanelli U; Ghiron C; Haydar S; Dunlop J; Terstappen GC
    J Pharmacol Exp Ther; 2009 May; 329(2):459-68. PubMed ID: 19223665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
    Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E
    Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and urinary excretion of DMXBA (GTS-21), a compound enhancing cognition.
    Mahnir V; Lin B; Prokai-Tatrai K; Kem WR
    Biopharm Drug Dispos; 1998 Apr; 19(3):147-51. PubMed ID: 9569996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and positron emission tomography studies of C-11-labeled isotopomers and metabolites of GTS-21, a partial alpha7 nicotinic cholinergic agonist drug.
    Kim SW; Ding YS; Alexoff D; Patel V; Logan J; Lin KS; Shea C; Muench L; Xu Y; Carter P; King P; Constanzo JR; Ciaccio JA; Fowler JS
    Nucl Med Biol; 2007 Jul; 34(5):541-51. PubMed ID: 17591554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal domains in mouse and human 5-hydroxytryptamine3A receptors confer partial agonist and antagonist properties to benzylidene analogs of anabaseine.
    Zhang R; White NA; Soti FS; Kem WR; Machu TK
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1276-84. PubMed ID: 16551836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and disposition of GTS-21, a novel drug for Alzheimer's disease.
    Azuma R; Komuro M; Korsch BH; Andre JC; Onnagawa O; Black SR; Mathews JM
    Xenobiotica; 1999 Jul; 29(7):747-62. PubMed ID: 10456692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia and the alpha7 nicotinic acetylcholine receptor.
    Martin LF; Freedman R
    Int Rev Neurobiol; 2007; 78():225-46. PubMed ID: 17349863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzylidene anabaseines act as high-affinity agonists for insect nicotinic acetylcholine receptors.
    Sultana I; Hosokawa C; Nishimura K; Ikeda I; Ozoe Y
    Insect Biochem Mol Biol; 2002 Jun; 32(6):637-43. PubMed ID: 12020838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.